Naproxen Directly Linked To GI Bleeding In 32% Of Cases Reviewed By FDA
This article was originally published in The Tan Sheet
Executive Summary
Nearly one-third of gastrointestinal hemorrhage cases related to OTC naproxen sodium use did not involve additional risk factors, FDA reports in a recently released postmarketing safety review